Home / Pharmaceutical / Global Genital Herpes Treatment Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026

Global Genital Herpes Treatment Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026

Published: Jan 2019 | Published By: Acute Market Research

The global genital herpes treatment drugs market is expected to expand at a CAGR of 4.9% from 2018 to 2026.

Market Insights

Genital herpes is the most common form of sexually transmitted disease in sexually active person. In the earlier stage of infection there are no visible symptoms reported but as the disease progresses genital lesions, cold sores, abnormal discharge and excruciating pain during micturition are clinically manifested. It is spread through oral, vaginal and anal contact. It is important to note that herpes infection is not cured only the symptoms are suppressed to promote relief in the ailing patients. Safe sex practice, early diagnosis and genital hygiene are the best preventive care to curb the spread of genital herpes infection. There is a changing trend in the treatment of genital herpes infection, wherein biologist are primarily focusing on developing vaccines to bolster immunity in ailing patients and address the problem of lesion recurrence.

Acyclovir is presently dominating the drug class for the genital herpes treatment drugs market. The primary features responsible for the dominance of acyclovir are its excellent therapeutic efficacy, dose tolerance with negligible toxicity. It is currently the drug of first choice for the treatment of genital herpes with a prescribed dose of 200 mg five times daily for 10 days. Famciclovir has gained prominence on account of its higher oral bioavailability which is employed for the treatment of genital herpes patients suffering with lesion recurrence.

North America is currently reigning the geographical segment for genital herpes treatment drugs market. According to Center for Disease Control and Prevention (CDC), genital herpes is occurring 1in every 6 citizens in the United States. Rising prevalence of sexually transmitted disease and effective treatment guidelines drive the genital herpes treatment drugs market growth in North America. Affordable reimbursement scenario and domicile of major players such as AstraZeneca, Plc., GlaxoSmithkline, Plc. & Novartis AG. Propel the genital herpes treatment drugs market growth in the European region. Asia Pacific will register rapid growth during the forecast period from 2018 to 2026 owing to the rising prevalence of HSV-1 infected patients, increasing public health awareness and presence of huge generic drugs for the treatment of genital herpes infection.

Pharmaceutical companies providing medication for the treatment of genital herpes infection are AstraZeneca, Plc., Apotheca, Inc., Asahi Kasei Pharma Corporation, Carlsbad Technology, Inc., GlaxoSmithkline, Plc., Mylan N.V., Novartis AG., Merck & Co., Inc., Teva Pharmaceutical Industries Ltd. and Zydus Pharmaceuticals, Inc.

Key Market Movements:

• Rising prevalence of sexually transmitted disease worldwide
• Increasing public health awareness and affordable reimbursement scenario drive the genital herpes treatment drugs market
• Excellent product pipeline catering therapeutics vaccines to bolster patient immunity such as GEN-003 and VCL-HB01

Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global Genital Herpes Treatment Drugs Market Portraiture
2.2. Global Genital Herpes Treatment Drugs Market, by Drug Class, 2017 (US$ Mn)
2.3. Global Genital Herpes Treatment Drugs Market, by Geography, 2017 (US$ Mn)

Chapter 3. Genital Herpes Treatment Drugs Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global Genital Herpes Treatment Drugs Market, by Key Players, 2017

Chapter 4. Global Genital Herpes Treatment Drugs Market, by Drug Class
4.1. Overview
4.2. Acyclovir
4.3. Famciclovir
4.4. Valacyclovir
4.5. Pipeline Analysis
4.5.1. Phase III Drugs
4.5.1.1. GEN-003
4.5.1.2. VCL-HB01
4.5.2. Tabular Representation of Drug Pipeline in Phase II and I

Chapter 5. Global Genital Herpes Treatment Drugs Market, by Geography
5.1. Overview
5.2. North America Genital Herpes Treatment Drugs Market Analysis, 2016 – 2026
5.2.1. North America Genital Herpes Treatment Drugs Market, by Drug Class, 2016 – 2026 (US$ Mn)
5.2.2. North America Genital Herpes Treatment Drugs Market, by Country, 2016 – 2026 (US$ Mn)
5.2.2.1. U.S.
5.2.2.2. Canada
5.3. Europe Genital Herpes Treatment Drugs Market Analysis, 2016 – 2026
5.3.1. Europe Genital Herpes Treatment Drugs Market, by Drug Class, 2016 – 2026 (US$ Mn)
5.3.2. Europe Genital Herpes Treatment Drugs Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.3.2.1. U.K.
5.3.2.2. Germany
5.3.2.3. Rest of Europe
5.4. Asia Pacific Genital Herpes Treatment Drugs Market Analysis, 2016 – 2026
5.4.1. Asia Pacific Genital Herpes Treatment Drugs Market, by Drug Class, 2016 – 2026 (US$ Mn)
5.4.2. Asia Pacific Genital Herpes Treatment Drugs Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.4.2.1. China
5.4.2.2. Japan
5.4.2.3. Rest of Asia Pacific
5.5. Latin America Genital Herpes Treatment Drugs Market Analysis, 2016 – 2026
5.5.1. Latin America Genital Herpes Treatment Drugs Market, by Drug Class, 2016 – 2026 (US$ Mn)
5.5.2. Latin America Genital Herpes Treatment Drugs Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.5.2.1. Brazil
5.5.2.2. Mexico
5.5.2.3. Rest of Latin America
5.6. Middle East and Africa Genital Herpes Treatment Drugs Market Analysis, 2016 – 2026
5.6.1. MEA Genital Herpes Treatment Drugs Market, by Drug Class, 2016 – 2026 (US$ Mn)
5.6.2. MEA Genital Herpes Treatment Drugs Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.6.2.1. GCC
5.6.2.2. Rest of MEA

Chapter 6. Company Profiles
6.1. AstraZeneca, Plc.
6.1.1. Business Description
6.1.2. Financial Information (Subject to data availability)
6.1.3. Product Portfolio
6.1.4. News Coverage
6.2. Apotheca, Inc.
6.3. Asahi Kasei Pharma Corporation
6.4. Carlsbad Technology, Inc.
6.5. GlaxoSmithKline plc.
6.6. Mylan N.V.
6.7. Novartis AG
6.8. Merck & Co., Inc.
6.9. Teva Pharmaceutical Industries Ltd.
6.10. Zydus Pharmaceuticals, Inc.

TABLE 1 Global Genital Herpes Treatment Drugs Market Portraiture
TABLE 2 Global Genital Herpes Treatment Drugs Market, by Drug Class, 2016 – 2026 (US$ Mn)
TABLE 3 Global Genital Herpes Treatment Drugs Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 4 North America Genital Herpes Treatment Drugs Market, by Drug Class, 2016 – 2026 (US$ Mn)
TABLE 5 North America Genital Herpes Treatment Drugs Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 6 Europe Genital Herpes Treatment Drugs Market, by Drug Class, 2016 – 2026 (US$ Mn)
TABLE 7 Europe Genital Herpes Treatment Drugs Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 8 Asia Pacific Genital Herpes Treatment Drugs Market, by Drug Class, 2016 – 2026 (US$ Mn)
TABLE 9 Asia Pacific Genital Herpes Treatment Drugs Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 10 Latin America Genital Herpes Treatment Drugs Market, by Drug Class, 2016 – 2026 (US$ Mn)
TABLE 11 Latin America Genital Herpes Treatment Drugs Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 12 Middle East and Africa Genital Herpes Treatment Drugs Market, by Drug Class, 2016 – 2026 (US$ Mn)
TABLE 13 Middle East and Africa Genital Herpes Treatment Drugs Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 14 AstraZeneca, Plc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 15 Apotheca, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 16 Asahi Kasei Pharma Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 17 Carlsbad Technology, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 18 GlaxoSmithkline, Plc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 19 Mylan N.V.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 20 Novartis AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21 Merck & Co., Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 Teva Pharmaceuticals Industries Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 Zydus Pharmaceuticals, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)

FIG. 1 Genital Herpes Treatment Drugs Market: Research Methodology
FIG. 2 Genital Herpes Treatment Drugs: Market Segmentation
FIG. 3 Global Genital Herpes Treatment Drugs Market, by Drug Class, 2017 (US$ Mn)
FIG. 4 Global Genital Herpes Treatment Drugs Market, by Geography, 2017 (US$ Mn)
FIG. 5 Attractive Investment Proposition: by Geography, 2017
FIG. 6 Competitive Analysis: Global Genital Herpes Treatment Drugs Market, by Key Players, 2017
FIG. 7 Global Acyclovir Drug Market for Genital Herpes Treatment, 2016 – 2026 (US$ Mn)
FIG. 8 Global Famciclovir Drug Market for Genital Herpes Treatment, 2016 – 2026 (US$ Mn)
FIG. 9 Global Valacyclovir Drug Market for Genital Herpes Treatment, 2016 – 2026 (US$ Mn)
FIG. 10 U.S. Genital Herpes Treatment Drugs Market, 2016 – 2026 (US$ Mn)
FIG. 11 Canada Genital Herpes Treatment Drugs Market, 2016 – 2026 (US$ Mn)
FIG. 12 U.K. Genital Herpes Treatment Drugs Market, 2016 – 2026 (US$ Mn)
FIG. 13 Germany Genital Herpes Treatment Drugs Market, 2016 – 2026 (US$ Mn)
FIG. 14 Rest of Europe Genital Herpes Treatment Drugs Market, 2016 – 2026 (US$ Mn)
FIG. 15 China Genital Herpes Treatment Drugs Market, 2016 – 2026 (US$ Mn)
FIG. 16 Japan Genital Herpes Treatment Drugs Market, 2016 – 2026 (US$ Mn)
FIG. 17 Rest of Asia Pacific Genital Herpes Treatment Drugs Market, 2016 – 2026 (US$ Mn)
FIG. 18 Brazil Genital Herpes Treatment Drugs Market, 2016 – 2026 (US$ Mn)
FIG. 19 Mexico Genital Herpes Treatment Drugs Market, 2016 – 2026 (US$ Mn)
FIG. 20 Rest of Latin America Genital Herpes Treatment Drugs Market, 2016 – 2026 (US$ Mn)
FIG. 21 GCC Genital Herpes Treatment Drugs Market, 2016 – 2026 (US$ Mn)
FIG. 22 Rest of MEA Genital Herpes Treatment Drugs Market, 2016 – 2026 (US$ Mn)

Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +